|
1
|
Bogomolov AN, Kozlov KL, Kurochkina ON and
Olesiuk IB: Coronary stenting in elderly patients with acute
myocardial infarction (review). Adv Gerontol. 26:151–160. 2013.(In
Russian). PubMed/NCBI
|
|
2
|
Wartenberg KE: Malignant middle cerebral
artery infarction. Curr Opin Crit Care. 18:152–163. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yang G, Min D, Yan J, Yang M and Lin G:
Protective role and mechanism of snakegourd peel against myocardial
infarction in rats. Phytomedicine. 42:18–24. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bakhta O, Blanchard S, Guihot AL,
Tamareille S, Mirebeau-Prunier D, Jeannin P and Prunier F:
Cardioprotective role of colchicine against inflammatory injury in
a rat model of acute myocardial infarction. J Cardiovasc Pharmacol
Ther. 23:446–455. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Senthil S, Chandramohan G and Pugalendi
KV: Isomers (oleanolic and ursolic acids) differ in their
protective effect against isoproterenol-induced myocardial ischemia
in rats. Int J Cardiol. 119:131–133. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Grimm D, Elsner D, Schunkert H, Pfeifer M,
Griese D, Bruckschlegel G, Muders F, Riegger GA and Kromer EP:
Development of heart failure following isoproterenol administration
in the rat: Role of the renin-angiotensin system. Cardiovasc Res.
37:91–100. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang GX, Kimura S, Nishiyama A, Shokoji
T, Rahman M, Yao L, Nagai Y, Fujisawa Y, Miyatake A and Abe Y:
Cardiac oxidative stress in acute and chronic isoproterenol-infused
rats. Cardiovasc Res. 65:230–238. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang SB, Tian S, Yang F, Yang HG, Yang XY
and Du GH: Cardioprotective effect of salvianolic acid A on
isoproterenol-induced myocardial infarction in rats. Eur J
Pharmacol. 615:125–132. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhou R, He LF, Li YJ, Shen Y, Chao RB and
Du JR: Cardioprotective effect of water and ethanol extract of
Salvia miltiorrhiza in an experimental model of myocardial
infarction. J Ethnopharmacol. 139:440–446. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Padmanabhan M and Prince PSM: Effects of
pharmacological amounts of S-allylcysteine on lipids in normal and
isoproterenol-induced myocardial infarction in rats. J Sci Food
Agric. 86:772–777. 2006. View Article : Google Scholar
|
|
11
|
Cheng J, Luo X, Huang Z and Chen L:
Apelin/APJ system: A potential therapeutic target for endothelial
dysfunction-related diseases. J Cell Physiol. Dec 26–2018.(Epub
ahead of print).
|
|
12
|
Tatemoto K, Hosoya M, Habata Y, Fujii R,
Kakegawa T, Zou MX, Kawamata Y, Fukusumi S, Hinuma S, Kitada C, et
al: Isolation and characterization of a novel endogenous peptide
ligand for the human APJ receptor. Biochem Biophys Res Commun.
251:471–476. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chong KS, Gardner RS, Morton JJ, Ashley EA
and McDonagh TA: Plasma concentrations of the novel peptide apelin
are decreased in patients with chronic heart failure. Eur J Heart
Fail. 8:355–360. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen MM, Ashley EA, Deng DX, Tsalenko A,
Deng A, Tabibiazar R, Ben-Dor A, Fenster B, Yang E, King JY, et al:
Novel role for the potent endogenous inotrope apelin in human
cardiac dysfunction. Circulation. 108:1432–1439. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tao J, Zhu W, Li Y, Xin P, Li P, Liu M, Li
J, Redington AN and Wei M: Apelin-13 protects the heart against
ischemia-reperfusion injury through inhibition of ER-dependent
apoptotic pathways in a time-dependent fashion. Am J Physiol Heart
Circ Physiol. 301:H1471–H1486. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kang K, Tarchick MJ, Yu X, Beight C, Bu P
and Yu M: Carnosic acid slows photoreceptor degeneration in the
Pde6b(rd10) mouse model of retinitis pigmentosa. Sci Rep.
6:226322016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wu YZ, Qiao F, Xu GW, Zhao J, Teng JF, Li
C and Deng WJ: Neuroprotective metabolites from the endophytic
fungus Penicillium citrinum of the mangrove Bruguiera gymnorrhiza.
Phytochem Lett. 12:148–152. 2015. View Article : Google Scholar
|
|
18
|
Liu Z, Xie L, Bian T, Qi G and Wang Z:
(3R)-5,6,7-trihydroxy-3-isopropyl-3-methylisochroman-1-one reduces
lipoteichoic acid-induced damage in rat cardiomyoblast cells.
Anatol J Cardiol. 19:198–204. 2018.PubMed/NCBI
|
|
19
|
Ministry of Science and Technology, .
Current Laboratory Animal Laws Regulations. Policies and
Administration in China. 2018.
|
|
20
|
Chen DY, Yang F and Lin YQ:
Neuroprotective constituent from the seeds of Alpinia
katsumadai Hayata. Phytochem Lett. 18:59–63. 2016. View Article : Google Scholar
|
|
21
|
Mondal MI and Yeasmin MS: Toxicity study
of food-grade carboxymethyl cellulose synthesized from maize husk
in Swiss albino mice. Int J Biol Macromol. 92:965–971. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li L, Zhou X, Li N, Sun M, Lv J and Xu Z:
Herbal drugs against cardiovascular disease: Traditional medicine
and modern development. Drug Discov Today. 20:1074–1086. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang X, Wang Q, Guo W and Zhu YZ: Hydrogen
sulfide attenuates cardiac dysfunction in a rat model of heart
failure: A mechanism through cardiac mitochondrial protection.
Biosci Rep. 31:87–98. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Abbate A, Biondi-Zoccai GG, Bussani R,
Dobrina A, Camilot D, Feroce F, Rossiello R, Baldi F, Silvestri F,
Biasucci LM and Baldi A: Increased myocardial apoptosis in patients
with unfavorable left ventricular remodeling and early symptomatic
post-infarction heart failure. J Am Coll Cardiol. 41:753–760. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ahmet I, Krawczyk M, Heller P, Moon C,
Lakatta EG and Talan MI: Beneficial effects of chronic
pharmacological manipulation of beta-adrenoreceptor subtype
signaling in rodent dilated ischemic cardiomyopathy. Circulation.
110:1083–1090. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Soga M, Kamal FA, Watanabe K, Ma M,
Palaniyandi S, Prakash P, Veeraveedu P, Mito S, Kunisaki M,
Tachikawa H, et al: Effects of angiotensin II receptor blocker
(candesartan) in daunorubicin-induced cardiomyopathic rats. Int J
Cardiol. 110:378–385. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yuan J, Adamski R and Chen J: Focus on
histone variant H2AX: To be or not to be. FEBS Lett. 584:3717–3724.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kuo LJ and Yang LX: Gamma-H2AX-a novel
biomarker for DNA double-strand breaks. In Vivo. 22:305–309.
2008.PubMed/NCBI
|
|
30
|
Xin BR, Liu JF, Kang J and Chan WP: (2R,
3S)-pinobanksin-3-cinnamate, a new flavonone from seeds of Alpinia
galanga willd., presents in vitro neuroprotective effects. Mol Cell
Toxicol. 10:165–172. 2014. View Article : Google Scholar
|
|
31
|
Kirkland RA and Franklin JL: Bax, reactive
oxygen, and cytochrome c release in neuronal apoptosis. Antioxid
Redox Signal. 5:589–596. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Brunelle JK and Letai A: Control of
mitochondrial apoptosis by the Bcl-2 family. J Cell Sci.
122:437–441. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Cory S and Adams JM: The Bcl2 family:
Regulators of the cellular life-or-death switch. Nat Rev Cancer.
2:647–656. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
34
|
Adibhatla RM and Hatcher JF: Lipid
oxidation and peroxidation in CNS health and disease: From
molecular mechanisms to therapeutic opportunities. Antioxid Redox
Signal. 12:125–169. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wang X and Michaelis EK: Selective
neuronal vulnerability to oxidative stress in the brain. Front
Aging Neurosci. 2:122010.PubMed/NCBI
|
|
36
|
Kuroda J and Sadoshima J: NADPH oxidase
and cardiac failure. J Cardiovasc Transl Res. 3:314–320. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kuroda J, Ago T, Matsushima S, Zhai P,
Schneider MD and Sadoshima J: NADPH oxidase 4 (Nox4) is a major
source of oxidative stress in the failing heart. Proc Natl Acad Sci
USA. 107:15565–15570. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Halliwell B: Oxidative stress and
neurodegeneration: Where are we now? J Neurochem. 97:1634–1658.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Birben E, Sahiner UM, Sackesen C, Erzurum
S and Kalayci O: Oxidative stress and antioxidant defense. World
Allergy Organ J. 5:9–19. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Itoh K, Wakabayashi N, Katoh Y, Ishii T,
Igarashi K, Engel JD and Yamamoto M: Keap1 represses nuclear
activation of antioxidant responsive elements by Nrf2 through
binding to the amino-terminal Neh2 domain. Genes Dev. 13:76–86.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kobayashi M and Yamamoto M: Nrf2-Keap1
regulation of cellular defense mechanisms against electrophiles and
reactive oxygen species. Adv Enzyme Regul. 46:113–140. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Medhurst AD, Jennings CA, Robbins MJ,
Davis RP, Ellis C, Winborn KY, Lawrie KW, Hervieu G, Riley G,
Bolaky JE, et al: Pharmacological and immunohistochemical
characterization of the APJ receptor and its endogenous ligand
apelin. J Neurochem. 84:1162–1172. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Berry MF, Pirolli TJ, Jayasankar V,
Burdick J, Morine KJ, Gardner TJ and Woo YJ: Apelin has in vivo
inotropic effects on normal and failing hearts. Circulation 110 (11
Suppl 1). II187–II193. 2004.
|
|
44
|
Kuba K, Zhang L, Imai Y, Arab S, Chen M,
Maekawa Y, Leschnik M, Leibbrandt A, Markovic M, Schwaighofer J, et
al: Impaired heart contractility in Apelin gene-deficient mice
associated with aging and pressure overload. Circ Res. 101:e32–e42.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Japp AG and Newby DE: The apelin-APJ
system in heart failure: Pathophysiologic relevance and therapeutic
potential. Biochem Pharmacol. 75:1882–1892. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
He L, Xu J, Chen L and Li L: Apelin/APJ
signaling in hypoxia-related diseases. Clin Chim Acta. 451:191–198.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Yu XH, Tang ZB, Liu LJ, Qian H, Tang SL,
Zhang DW, Tian GP and Tang CK: Apelin and its receptor APJ in
cardiovascular diseases. Clin Chim Acta. 428:1–8. 2014. View Article : Google Scholar : PubMed/NCBI
|
